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Treatment of Catatonia with an 
Anticholinergic Agent 
To the Editor: 
In their recent overview, "'Benzodiazepines and 
Ca:atonia," Menza and Harris (1989) describe nu- 
merous theories regarding the response of catatonic 
symptoms to benzodi~zepines. Among these, they 
state that, "[Llow doses of GABA agonists reduce 
cholinergic activity in the basal ganglia," while, 
"[Hligher doses of GABA agonists reduce both do- 
paminergic and cholinergic activity." There is an 
analogy to the model of muscarinic-dopaminergic hy- 
peractivity in schizophrenia proposed by Tandon and 
Greden (1989), where increased muscarinic activity 
has been implicated in the production of negative 
schizophrenic symptoms. Panzer et al (1990) have 
suggested that it may account for catatonia in some 
cases as well. Although cholinergic activity has pre- 
viously beel~ !inked to catatonia (Van Andel 1958), 
Panzer et al reported the first case of a patient with 
schizoaffective disorder in whom catatonia was treated 
with an anticholinergic agent. We report the first case 
of catatonia in a patient with schizophrenia that was 
successfully treated with a parenteral anticholinergic 
agent. 
Mr. A is a 24-year-old man whose psychiatric 
history began 9 months prior to his admission. His 
wife described him as becoming paranoid and in- 
creasingly hostile without provocation; he was afraid 
that his wife would take his two children away from 
him. The couple separated shoRly thereafter, and the 
patient remained a_m_.biva!ent about the marriage. Mr. 
A was a! ~o using cocaine, marijuana, and alcohol at 
that time. 
Two months prior to admission, the patient began 
experiencing auditory hallucinations, displayed loose 
associations and social withdrawal, and made a su- 
icide attempt by pouring gasoline on his shi~, ~a.  
igniting it. Subsequent evaluation at a local hospital 
revealed normal laboratory values including electro- 
lyres, thyroid function tests, VDRL, EEG, and com- 
puted tomography of the head without contrast. He 
was transferred to the University of Michigan Hos- 
pital, but left against medical advice the following 
day. According to his family, Mr. A's psychotic 
symptoms cleared somewhat over the next several 
days. 
Shortly thereafter, however, his level of func- 
tioning again deteriorated. Mr. A quit his job of 2 
years, and became more disorganized; he became 
withdrawn, his affect was flat, and his personal hy- 
giene was poor. He had markedly decreased speech 
production with severe psychomotor retardation. 
Upon readmission Mr. A was noted to have in- 
creased rigidity, heightened startle response, and an 
absence of spontaneous movements; he was essen- 
tially mute. Although muscle tone was increased, 
there was no "'waxy flexibility." Laboratory values 
(including ceruloplasmin, VDRL, and thyroid func- 
tion tests) again were normal except for ketones on 
uo.'nalysis, and mildly elevated calcium, protein, al- 
bumin, and total bilirubin, all of which returned to 
normal within a few days without treatment. Urine 
toxicology screen was only positive iot oiphenhy- 
dramine (which by our assay may persist in the urine 
for more than a week after the last dose.) Chest ra- 
diograph and magnetic resonance imaging of the head 
were both normal. Neurological consult concurred 
with our assessment of psychogenic catatonia (Fric- 
chione 1985). 
Intravenous hydration was begun as the patient 
was unable to take anything by ~,ulh.  After 24 hr 
of hydration without improvement, the patient was 
given 2 mg of benztropine intravenously in an attempt 
to treat his catatonia. There was minimal response to 
the initial dose, and another 2 mg was given l hr 
later. Within 60 min, the patient was able to answer 
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questions readily. He would initially only speak in 
one or two word sentences, but progressively became 
more verbal. He was gradually able to attend to his 
person.~l hygiene, feed himself, and walk around the 
unit with assistance: these changes occurred over the 
course of 2 days. Mr. A still complained of auditory 
hallucinations at this time. He was subsequently be- 
gun on thiothixene and benztropine and continued to 
improve. Within several days he denied any hallu- 
cinations or delusions, but remained somewhat 
guarded. There was no recurrence of catatonic symp- 
toms during the ~mainder of his hospitalization, and 
the patient was discharged after 2 weeks in good 
condition with the diagnoses of schizophrenia and 
polysubstance abuse. 
The rapid response of catatonic symptoms in this 
first-break, medication-naive patient to a parenteral 
anticholinergic agent lends suppewt to the theory that 
a disproportionately high degree of cholinergic tone 
may be responsible for the observed catatonic symp- 
toms. As this is only the second case reported by our 
institution (Panzer et al 1990), a cautious interpre- 
tation of these data is required. Clearly, future con- 
trolled studies are in order. Nonetheless, our findings 
support the conclusions of Menza and Harris regard- 
ing a possible anticholinergic mechanism of benzo- 
diazepine treatment of catatonia. An increase in cno- 
linergic activity may be one mechanism underlying 
disorders such as negative schizophrenia symptoms 
and catatonia. 
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Response 
To the Editor: 
This report by Drs. Albucher, DeQuardo, and 
Tandon is now the second report in which a patient 
with a "psychogenic" catatonia appears to have re- 
sponded to an anticholinergic agent. As they point 
out, and as we have speculated in the past, this re- 
sponse may be relevant to the widely reported use- 
fulness of the benzodiazepines in catatonia (Menza 
and Harris 1989). 
Assuming that this response is reproducible under 
more controlled conditions, there are a number of 
possible implic~ons. The model of catatonia as a 
dopaminergic/cholinergic imbalance fits nicely with 
these case reports but one ~aust be careful in making 
too much of very little ~Jat~,. The data are also con- 
sistent with our sFeculations concerning cemplex par- 
tial seizures activity, because limbic electrical dis- 
charges are suppressed by anticholinergic agents 
(Meldrum 1984). Whatever the mechanism, we look 
forward to further cor, a~,,iled data on anticholinergic 
age~,.s and catatonia. 
Matthew A. Menza 
Department of Psychiatry 
UMDNJ 
Robert Wood Johnson Medical School 
New Brunswick, NJ 08903 
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